Skip to main content
. 2022 Feb 23;11:1–8. doi: 10.14283/jarlife.2022.1

Table 2.

Participants carrying APOE E3E3 and E3E4 in CN Group

2a Number of participants by APOE status
APOE bl m0 m1 m2 m3 m4 m6
Status 6 2 4 6 8 0
E3E3 158 157 152 145 83 124 71
E3E4 62 60 60 59 29 47 26
2b Number of participants by APOE status and risk score
Characteristics bl bl m0 m0 m1 m1 m2 m2 m3 m3 m4 m4 m6 m6
6 6 2 2 4 4 6 6 8 8 0 0
APOE E3E E3E E3E E3E E3E E3E E3E E3E E3E E3E E3E E3E E3E E3E
Status 3 4 3 4 3 4 3 4 3 4 3 4 3 4
High 45 58 45 56 42 56 39 55 19 26 33 44 20 23
Low 113 4 112 4 110 4 106 4 64 3 91 3 51 3

bl: baseline; m: month. Thus month 6 is represented by m06